|
|
|
|
| LEADER |
00000csc a2200000 a 4500 |
| 001 |
26929-3 |
| 005 |
20230308214926.0 |
| 008 |
002122|2001 ||||||||r|||||||||||spa|| |
| 020 |
|
|
|a 9701038126
|
| 040 |
|
|
|b spa
|
| 041 |
1 |
|
|a spa
|
| 082 |
0 |
|
|a 617
|
| 245 |
|
|
|a Páncreas, parte II: tumores benignos y malignos, criterio interdisciplinario
|c Avram M. Cooperman y Ronald S. Chamberlain, directores; Santiago Sapiña Renard traductor
|h imp
|n 3/6
|
| 264 |
|
|
|a México
|b McGraw-Hill Interamericana
|c 2001
|
| 300 |
|
|
|a XIX, pp 495-766
|b ilu
|
| 300 |
|
|
|c 22x16 cm
|
| 310 |
|
|
|a Bimestral
|
| 490 |
|
|
|a Clínicas Quirúrgicas de Norteamérica
|v volumen 3/6
|
| 504 |
|
|
|a incl. ref.
|
| 650 |
1 |
|
|a Enfermedades pancreaticas
|9 85868
|
| 650 |
1 |
|
|a Neoplasmas pancreaticos
|9 297428
|
| 650 |
1 |
|
|a Cirugia
|
| 650 |
|
|
|a Tumores quísticos
|9 103723
|
| 650 |
|
|
|a Neoplasias quísticas
|9 296514
|
| 650 |
|
|
|a Neoplasias epiteliales benignas
|9 300707
|
| 650 |
|
|
|a Tumores neuroendocrinos
|9 2381
|
| 650 |
|
|
|a Células insulares
|9 300708
|
| 650 |
|
|
|a Cáncer periambular
|9 300709
|
| 650 |
|
|
|a Cáncer pancreático
|9 296513
|
| 650 |
|
|
|a Pancreas
|9 2357
|
| 700 |
1 |
|
|a Cooperman, Avram M
|e director
|9 298491
|
| 700 |
1 |
|
|a Chamberlain, Ronald S
|e director
|9 300710
|
| 700 |
|
|
|a Sapiña Renard, Santiago
|e traductor
|9 239332
|
| 773 |
|
|
|t Páncreas, parte II: tumores benignos y malignos, criterios interdisciplinarios
|
| 852 |
|
|
|a UC-SALUD
|c ESTANTERIA ABIERTA
|f Compra
|k rosa.mendez
|l 1
|m General
|p 20021226/20130717
|q $. 36.66
|t 26929-3
|b 0
|d CDRS
|e CDRS
|g 617 ESTANTERIA ABIERTA
|z 2002-21-22
|
| 942 |
|
|
|
| 999 |
|
|
|c 129374
|d 129374
|